ProteLight Pharma Focuses on R & D of Antimicrobial Peptide New Drugs -- Declare War on “Superbugs”


September 3th, 2019, “Economic Daily News•China Economic Net” published an article named “ProteLight focuses on R & D of antimicrobial peptide new drugs -- declare war on superbugs", it tells the hard R&D process about Dr. Yuxin Chen, the Chairman of Board of ProteLight Pharma, lead his team to develop antimicrobial peptide new drugs.


Report links